Showing results (61-70 of 181) with videos related to
Sort By:
Pageof 19
Artificial Cells, Nanomedicine, and Biotechnology|August 5, 2017
Electrokinetic potential-stabilization by bile acid-microencapsulating formulation of pancreatic β-cells cultured in high ratio poly-L-ornithine-gel hydrogel colloidal dispersion: applications in cell-biomaterials, tissue engineering and biotechnological applicationsArmin Mooranian, Rebecca Negrulj, Ryu Takechi, et al.Journal of Food Science|May 22, 2025
Multiresponse Surface Optimization of Ionic Gelation Vibrational Jet Flow Technology to Fine-Tune Kafirin Microparticles Extracted From Sorghum Dried Distiller's GrainUmar Shah, Rewati R Bhattarai, Hani Al Salami, et al.Archives of Drug Information|February 17, 2010
Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy RatsHani Al-Salami, Grant Butt, Ian Tucker, et al.Pharmaceutics|February 25, 2023
Novel Silicone-Grafted Alginate as a Drug Delivery Scaffold: Pharmaceutical Characterization of Gliclazide-Loaded Silicone-Based Composite MicrocapsulesAhmed Gedawy, Giuseppe Luna, Jorge Martinez, et al.Journal of Microencapsulation|July 21, 2015
Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro studyArmin Mooranian, Rebecca Negrulj, Momir Mikov, et al.Drug Delivery and Translational Research|January 10, 2018
The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effectsArmin Mooranian, Rebecca Negrulj, Ryu Takechi, et al.Pharmacological Research|January 8, 2019
Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoidsEmily Brook, John Mamo, Rachel Wong, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 2020
PAMPA model of gliclazide permeability: The impact of probiotic bacteria and bile acidsMaja Đanić, Nebojša Pavlović, Bojan Stanimirov, et al.Journal of Diabetes Research|May 15, 2013
Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a RatMladena Lalić-Popović, Velibor Vasović, Boris Milijašević, et al.European Journal of Drug Metabolism and Pharmacokinetics|November 15, 2008
The influence of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetesMomir Mikov, Hani Al-Salami, Svetlana Golocorbin-Kon, et al.Pageof 19